“…The amount of the non-capsulated drug in the supernatant was estimated spectrophotometrically at 269 nm, utilizing an ultraviolet spectrophotometer (Shimadzu, Yokohama, Japan). Different characterizations such as zeta potential (ZP), particle size as well as the polydispersity index (PDI) of the formulated nanoparticles were measured using a Zetasizer (Malvern Instruments Ltd., Malvern, UK) [ 40 , 41 ], while morphology of the surface of the nanoparticles was confirmed using transmission electron microscopy (TEM) (model JTEM-2100, Tokyo, Japan) [ 42 ]. Release of the drug from different trials was carried out using dialysis bag method [ 43 ] at simulated gastric fluid containing 0.1 N HCl and final pH equalsing 1.2 for 2 h and then substituted with phosphate buffer (pH = 6.8) for the next 10 h. Temperature was kept at 37 ± 1 °C, and drug was assayed spectrophotometrically at 269 nm (UV-visible spectrophotometer, Shimadzu, Yokohama, Japan) [ 44 ].…”